Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 16:14:1232488.
doi: 10.3389/fimmu.2023.1232488. eCollection 2023.

A fine mapping of single nucleotide variants and haplotype analysis of IL13 gene in patients with Leishmania guyanensis-cutaneous leishmaniasis and plasma cytokines IL-4, IL-5, and IL-13

Affiliations

A fine mapping of single nucleotide variants and haplotype analysis of IL13 gene in patients with Leishmania guyanensis-cutaneous leishmaniasis and plasma cytokines IL-4, IL-5, and IL-13

José do Espírito Santo Junior et al. Front Immunol. .

Abstract

Introduction: Leishmaniasis continues to pose a substantial health burden in 97 countries worldwide. The progression and outcome of Leishmania infection are influenced by various factors, including the cytokine milieu, the skin microbiota at the infection site, the specific Leishmania species involved, the genetic background of the host, and the parasite load. In endemic regions to leishmaniasis, only a fraction of individuals infected actually develops the disease. Overexpression of IL-13 in naturally resistant C57BL/6 mice renders them susceptible to L. major infection. Haplotypes constructed from several single nucleotide variant (SNV) along a chromosome fragment may provide insight into any SNV near the fragment that may be genuinely associated with a phenotype in genetic association studies.

Methods: We investigated nine SNVs (SNV1rs1881457A>C, SNV2rs1295687C>G, SNV3rs2069744C>T, SNV4rs2069747C>T, SNV5rs20541A>G, SNV6rs1295685A>G, SNV7rs848A>C, SNV8rs2069750G >C, and SNV9rs847T>C) spanning the entire IL13 gene in patients with L. guyanensis cutaneous leishmaniasis (Lg-CL).

Results: Our analysis did not reveal any significant association between the SNVs and susceptibility/protection against Lg-CL development. However, haplotype analysis, excluding SNV4rs2069747 and SNV8rs2069750 due to low minor allele frequency, revealed that carriers of the haplotype CCCTAAC had a 93% reduced likelihood developing Lg-CL. Similarly, the haplotypes ACCCGCT (ORadj=0.02 [95% CI 0.00-0.07]; p-value, 6.0×10-19) and AGCTAAC (ORadj=0.00[95% CI 0.00-0.00]; p-value 2.7×10-12) appeared to provide protection against the development of Lg-CL. Conversely, carriers of haplotype ACCTGCC have 190% increased likelihood of developing Lg-CL (ORadj=2.9 [95%CI 1.68-5.2]; p-value, 2.5×10-6). Similarly, haplotype ACCCAAT (ORadj=2.7 [95%CI 1.5-4.7]; p-value, 3.2×10-5) and haplotype AGCCGCC are associated with susceptibility to the development of Lg-CL (ORadj=1.7[95%CI 1.04-2.8]; p-value, 0.01). In our investigation, we also found a correlation between the genotypes of rs2069744, rs20541, rs1295685, rs847, and rs848 and plasma IL-5 levels among Lg-Cl patients. Furthermore, rs20541 showed a correlation with plasma IL-13 levels among Lg-Cl patients, while rs2069744 and rs848 showed a correlation with plasma IL-4 levels among the same group.

Conclusions: Overall, our study identifies three haplotypes of IL13 associated with resistance to disease development and three haplotypes linked to susceptibility. These findings suggest the possibility of a variant outside the gene region that may contribute, in conjunction with other genes, to differences in susceptibility and partially to the pathology.

Keywords: IL-13; Leishmania guyanensis; cutaneous leishmaniasis; single nucleotide variants; susceptibility.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Distribution of the nine single nucleotide variants studied on the gene IL13. IL13 gene figure displaying the genomic regions for each variant, rs1881457 (promoter), rs1295687 and rs2069744 (intron 1), rs2069747 (intron2), rs20541 (exon4), rs1295685, rs848, rs2069750, and rs847 (3′ untranslated region).
Figure 2
Figure 2
Linkage disequilibrium structure among the nine single nucleotide variants of the IL13.
Figure 3
Figure 3
Effects of genotypes rs2069744 and rs848 on circulating plasma IL-4 based on a dominant genetic model while rs20541 on IL-13 in the codominant model. Mean of IL-13 concentrations were compared between the genotypes in patients with Lg-CL (CS), and in the Total (Lg-CL + HCs) by Generalized Linear Model (GLM) considering the inheritance models. P represents p-values adjusted for covariates age and sex. The means expressed in log (pg/mL) are represented by black dots, while the error bar is the standard error of the mean; boxplots in gray represent the median and quartiles and are used to show the distance between mean and median. Post-hoc analysis for rs20541/IL-13 using the postHoc package. ns, not significant.
Figure 4
Figure 4
Effects of genotypes rs2069744, rs20541, rs129685, rs848, and rs847 on circulating plasma IL-5 based on different genetic model. The mean of IL-13 concentrations was compared between genotypes in patients with Lg-CL (CS), HCs (healthy controls), and Total (Lg-CL+HC) by Generalized Linear Model (GLM) considering the inheritance models. P represents p-values adjusted for covariates age and sex. The means expressed in log (pg/mL) are represented by black dots, while the error bar is the standard error of the mean; boxplots in gray represent the median and quartiles and are used to show the distance between mean and median. Post-hoc analysis for rs2069744, rs20541, rs1295685, rs848, and rs847 using the postHoc package. p-value <*0.05, **0.01, ***0.001. ns, not significant.

References

    1. World Health Organisation. Leishmaniasis (2022). Available at: https://www.who.int/news-room/fact-heets/detail/leishmaniasis (Accessed April, 2023).
    1. Bern C, Maguire JH, Alvar J. Complexities of assessing the disease burden attributable to leishmaniasis. PloS Negl Trop Dis (2008) 2(10):e313. doi: 10.1371/journal.pntd.0000313 - DOI - PMC - PubMed
    1. Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. . Leishmaniasis worldwide and global estimates of its incidence. PloS One (2012) 7(5):e35671. doi: 10.1371/journal.pone.0035671 - DOI - PMC - PubMed
    1. GBD 2013 DALYs and HALE Collaborators. Murray CJ, Barber RM, Foreman KJ, Abbasoglu Ozgoren A, Abd-Allah F, Abera SF, et al. . Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 386(10009):2145–91. doi: 10.1016/S0140-6736(15)61340-X - DOI - PMC - PubMed
    1. Gabriel Á, Valério-Bolas A, Palma-Marques J, Mourata-Gonçalves P, Ruas P, Dias-Guerreiro T, et al. . Cutaneous leishmaniasis: the complexity of host's effective immune response against a polymorphic parasitic disease. J Immunol Res (2019) 2019:2603730. doi: 10.1155/2019/2603730 - DOI - PMC - PubMed

Publication types

LinkOut - more resources